related documents
- ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY Conferences
- C-REACTIVE PROTEIN AS A BIOMARKER IN PEDIATRIC PATIENTS WITH RESPIRATORY VIRUS INFECTIONS Conferences
- CONTENT ANALYSIS OF BOWEL PROTOCOLS IN NORTH AMERICAN INTENSIVE CARE UNITS Conferences
- EVEROLIMUS-INDUCED PNEUMONITIS IN A PEDIATRIC PATIENT WITH TUBEROUS SCLEROSIS Conferences
- FACILITATORS ENABLING THE TRANSITION OF AN END-OF-LIFE RESEARCH PROJECT TO A CLINICAL PROGRAM Conferences
- HUMANIZING CRITICALLY ILL PATIENTS BY SHARING THEIR STORIES THROUGH THE FOOTPRINTS PROJECT Conferences
- NOT ALL THAT COUNTS CAN BE COUNTED: MANAGERIAL PERSPECTIVES OF THE 3 WISHES PROJECT Conferences
- PATIENT AND FAMILY ENGAGEMENT AT THE END OF LIFE: THE MULTICENTER 3 WISHES PROJECT Conferences
- THE EFFECT OF THE 3 WISHES PROJECT ON CLINICIANS: MAKING WORK MEANINGFUL Conferences
- THE FOOTPRINTS PROJECT: FACILITATING MULTIDISCIPLINARY COMMUNICATION IN THE INTENSIVE CARE UNIT Conferences
- THE USE OF THE CUFF LEAK TEST IN THE INTENSIVE CARE UNIT: INTERNATIONAL SURVEY Conferences
- VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING Conferences